Qymune
San Francisco
About Qymune
Qum Therapeutics Develops immunotherapies that target pathogenic cells. The company designs treatments to engage the patient’s immune system and control disease progression. Its approach focuses on precision targeting and minimizing side effects. The technology is applied to cancer and other diseases that involve pathogenic cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $11.0M
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: qumtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/qymune-87373 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.